Curated News
By: NewsRamp Editorial Staff
March 04, 2026
HeartBeam Partners with ClearCardio to Revolutionize Remote Cardiac Monitoring
TLDR
- HeartBeam's partnership with ClearCardio provides a strategic advantage by establishing its first commercial customer and securing investment for expansion in preventive cardiology markets.
- HeartBeam's cable-free 3D ECG system synthesizes signals into clinical-grade 12-lead readings for home use, integrated into ClearCardio's prevention programs through a subscription-based deployment plan.
- This technology enables accessible at-home cardiac monitoring, potentially improving early detection and preventive care while reducing hospital visits for better patient outcomes.
- HeartBeam's FDA-cleared 3D ECG system captures cardiac signals from three directions without cables, creating portable 12-lead readings using patented technology with over 20 patents.
Impact - Why it Matters
This partnership represents a significant advancement in accessible cardiac care that could transform how millions monitor their heart health. By enabling clinical-grade ECG readings from home through HeartBeam's FDA-cleared technology, patients gain unprecedented access to preventive cardiology services without frequent clinic visits. This development addresses critical healthcare challenges including early detection of arrhythmias, reduced healthcare costs through preventive care, and improved patient outcomes through continuous monitoring. For individuals with cardiac concerns or risk factors, this technology means potentially life-saving early intervention and more convenient management of heart conditions. The collaboration also signals a broader shift toward decentralized healthcare delivery, where sophisticated medical monitoring becomes integrated into daily life rather than confined to medical facilities.
Summary
HeartBeam (NASDAQ: BEAT), a pioneering medical technology company, has announced a groundbreaking commercial partnership with ClearCardio™, a leading preventive cardiology practice. This strategic alliance marks HeartBeam's first commercial customer and includes a planned investment from ClearCardio, signaling strong confidence in the technology. The partnership will integrate HeartBeam's revolutionary synthesized 12-lead ECG technology into ClearCardio's cardiac prevention programs, enabling patients to capture clinical-grade electrocardiogram readings from home using HeartBeam's patented cable-free 3D ECG system. This innovative approach represents a significant advancement in remote cardiac monitoring and preventive care.
The agreement, structured as a Letter of Intent with subscription-based commercial terms, supports HeartBeam's broader growth strategy into concierge care and preventive cardiology networks. HeartBeam's technology platform creates the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing them into a 12-lead ECG. This FDA-cleared technology, which received clearance for arrhythmia assessment in December 2024 and for 12-lead ECG synthesis software in December 2025, allows physicians to identify cardiac health trends and acute conditions outside traditional medical facilities. The company holds over 20 issued patents related to this transformative technology enablement.
This partnership represents a major step forward in transforming cardiac care through advanced cardiac insights, as detailed in the full press release available at https://ibn.fm/EDyjd. The collaboration between HeartBeam and ClearCardio demonstrates how medical technology companies are revolutionizing healthcare delivery by making sophisticated cardiac monitoring accessible outside clinical settings. This development is particularly significant given the growing emphasis on preventive cardiology and remote patient monitoring in modern healthcare systems, potentially changing how millions of people manage their heart health through personalized prevention programs and early detection capabilities.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, HeartBeam Partners with ClearCardio to Revolutionize Remote Cardiac Monitoring
